JPH0543707B2 - - Google Patents

Info

Publication number
JPH0543707B2
JPH0543707B2 JP837494A JP749483A JPH0543707B2 JP H0543707 B2 JPH0543707 B2 JP H0543707B2 JP 837494 A JP837494 A JP 837494A JP 749483 A JP749483 A JP 749483A JP H0543707 B2 JPH0543707 B2 JP H0543707B2
Authority
JP
Japan
Prior art keywords
solution
pharmaceutical composition
active substance
nitroprusside
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP837494A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58180489A (ja
Inventor
Shirupuka Heningu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPS58180489A publication Critical patent/JPS58180489A/ja
Publication of JPH0543707B2 publication Critical patent/JPH0543707B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP58007494A 1982-01-22 1983-01-21 ビス−(トリメタフアン)ニトロプルシツド Granted JPS58180489A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH388/82-5 1982-01-22
CH389/82-7 1982-01-22
CH38882 1982-01-22

Publications (2)

Publication Number Publication Date
JPS58180489A JPS58180489A (ja) 1983-10-21
JPH0543707B2 true JPH0543707B2 (enrdf_load_stackoverflow) 1993-07-02

Family

ID=4185862

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58007494A Granted JPS58180489A (ja) 1982-01-22 1983-01-21 ビス−(トリメタフアン)ニトロプルシツド

Country Status (3)

Country Link
JP (1) JPS58180489A (enrdf_load_stackoverflow)
BE (1) BE895669A (enrdf_load_stackoverflow)
ZA (1) ZA83271B (enrdf_load_stackoverflow)

Also Published As

Publication number Publication date
ZA83271B (en) 1983-11-30
JPS58180489A (ja) 1983-10-21
BE895669A (fr) 1983-07-22

Similar Documents

Publication Publication Date Title
KR100411380B1 (ko) 시스플라틴과2,2'-디티오-비스(에탄설포네이트)(디메스나)를포함하는조성물
EP0216459B1 (en) 9-substituted guanine monohydrates
EP0159917B1 (en) Pharmaceutical composition containing a hydroxypyrone-iron complex
UA77728C2 (en) Pharmaceutical composition of platinum compound (variants)
JP2003506416A (ja) モキシフロキサシン/塩化ナトリウム製剤
CA2421410C (en) Iron compositions
ES2283771T3 (es) Metodos para la formacion de compuestos de hidroc[xipirona de hierro.
JP2025123344A (ja) トランス-[テトラクロロビス(1h-インダゾール)ルテニウム酸(iii)]及びその組成物の製造
CA1160571A (en) Antitumor compositions
PL134004B1 (en) Method of stabilizing prostacycline and its analogons
JPH0543707B2 (enrdf_load_stackoverflow)
MXPA05000011A (es) Formulacion parenteral liquida estable de parecoxib.
US4740506A (en) Bis(trimethaphan)-nitroprusside salts and use thereof for blood pressure reduction
CZ20014269A3 (cs) Polymorfy krystalického azabicyklo[2.2.2]oktan-3-amin-citrátu a farmaceutické kompozice je obsahující
IE61995B1 (en) "Aqueous formulations containing a piperidinylcyclopentylheptenoic acid derivative"
CA1252103A (en) Crystalline gluconate salt of 4'-(9-acridinylamino)- methanesulfo-m-anisidide
US2092028A (en) Spirocheticide
CZ396292A3 (en) Pharmaceutical preparation for treating and prophylaxis of infection
JP3990728B2 (ja) N−[4−オキソ−2−(1h−テトラゾール−5−イル)−4h−1−ベンゾピラン−8−イル]−4−(4−フェニルブトキシ)ベンズアミドの塩
JPS6213922B2 (enrdf_load_stackoverflow)
KR820000208B1 (ko) 주사용액의 제조방법
CH656618A5 (en) Trimetaphan-nitroprusside, and pharmaceutical preparations containing this compound
IL31676A (en) Addition compound of 5,5-dimethyl-hydantoin and chloralhydrate,its preparation and pharmaceutical compositions containing it
JPH03120216A (ja) 骨髄の抑制用組成物
MXPA06006079A (en) Metal salts of parecoxib as prodrugs of the cox-2 inhibitor valdecoxib for the treatment of inflammation, pain and/or fever